Celyad CEO Filippo Petti On In-House Allogeneic Cell Therapy Manufacturing

We love to hear from our listeners. Send us a message.

Join Matt Pillar and Erin Harris as we catch up with Celyad Oncology chief Filippo Petti on his company's  differentiated approach to the discovery and development of allogeneic CAR-T cell therapy candidates for the treatment of cancer. Petti shares the technology and how the company intends to scale in-house manufacturing in its Belgium-based manufacturing facility.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.  

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/